Show Summary Details
Page of

Genetics of Age-Related Maculopathy 

Genetics of Age-Related Maculopathy
Genetics of Age-Related Maculopathy

Oluwatoyin Fafowora

and Michael B. Gorin

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2022. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 27 January 2022

Studies of the molecular genetics of age-related maculopathy (ARM) have dramatically transformed our understanding of this condition and have served as a major success in the study of age-related complex disorders. This review is intended to provide a brief description of this condition, which is responsible for significant vision loss throughout the world, and to summarize the findings from genetic studies within the context of ARM biology, and their relevance to future therapy and public health issues.

ARM is a degenerative condition affecting the retina, pigment epithelium, and choriocapillaris of the eye with particular predilection to the macular area, which is responsible for central vision. The current clinical terminology for ARM is confusing at best for the uninitiated. The more commonly used name for the condition, age-related macular degeneration (AMD or ARMD), was originally defined as either the association of specific ocular changes with vision loss of 20/40 or worse,1 or those clinical findings that were associated with vision loss (20/40 or worse) that could be specifically attributed to AMD.2 However, over time, clinicians have increasingly used the term for retinal changes that are not necessarily associated with vision loss. “Age-related maculopathy” covers the full spectrum of the disease and was adopted by many of those investigating the genetics of this condition since pre- or asymptomatic family members are very useful in genetic studies.3 In addition, a number of investigations have relied upon the masked grading of retinal photographs to determine a control or case status for the disease, without consideration of the visual acuity. The authors of this chapter prefer to use the term “age-related maculopathy.”

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.